soul semaglutide trial: Oral demonstrates a 14% reduction in risk of major adverse CV events soul trial oral semaglutide cardiovascular

TRIUMPH-1: Cardiometabolic Improvements (12mg, 80 weeks) Triglycerides: Reduced up to 41.0% Non-HDL cholesterol: Reduced up to 24.2% Systolic blood pressure: Reduced up to 12.3 mmHg Waist circumference: Reduced up to 24.1 cm hsCRP: Significant reduction (confirming systemic anti-inflammatory effect) TRIUMPH-1 vs

Unexpected Reactions : Consult a healthcare professional immediately if experiencing severe itching, health problems, or if the condition worsens instead of improving

If your sex drive feels lower than normal, give your body a stretch to catch upit usually sorts itself out as weight stabilizes

Report any of these symptoms immediately to your doctor

Last year, the U.S